<DOC>
	<DOCNO>NCT01096563</DOCNO>
	<brief_summary>This single centre , Double blind , Randomised , Placebo-controlled , Parallel group study access safety , tolerability , pharmacokinetics Inhaled AZD9164 administration single Multiple Ascending dose Japanese subject .</brief_summary>
	<brief_title>A Single Multiple Ascending Dose Study With AZD9164 Given 13 Days Healthy Male Female Japanese Subjects</brief_title>
	<detailed_description />
	<criteria>Healthy Japanese subject suitable vein cannulation repeat venipuncture Have body mass index ( BMI ) 18 27 kg/m2 body weight 50 85 kg Male subject willing use barrier contraception ie , condom spermicide , first day dose 3 month last dose investigational product History clinically significant disease disorder , opinion Investigator , may either put subject risk participation study , influence result subject 's ability participate study . History presence gastrointestinal , hepatic renal disease condition know interfere absorption , distribution , metabolism excretion drug Any clinically significant illness , medical/surgical procedure trauma within 4 week first administration investigational product</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>Phase I</keyword>
	<keyword>Japanese healthy volunteer</keyword>
	<keyword>AZD9164</keyword>
</DOC>